Autophagy in Neurodegenerative Diseases: A Hunter for Aggregates

Int J Mol Sci. 2020 May 10;21(9):3369. doi: 10.3390/ijms21093369.

Abstract

Cells have developed elaborate quality-control mechanisms for proteins and organelles to maintain cellular homeostasis. Such quality-control mechanisms are maintained by conformational folding via molecular chaperones and by degradation through the ubiquitin-proteasome or autophagy-lysosome system. Accumulating evidence suggests that impaired autophagy contributes to the accumulation of intracellular inclusion bodies consisting of misfolded proteins, which is a hallmark of most neurodegenerative diseases. In addition, genetic mutations in core autophagy-related genes have been reported to be linked to neurodegenerative diseases, such as Alzheimer's disease, Parkinson's disease, and Huntington's disease. Conversely, the pathogenic proteins, such as amyloid β and α-synuclein, are detrimental to the autophagy pathway. Here, we review the recent advances in understanding the relationship between autophagic defects and the pathogenesis of neurodegenerative diseases and suggest autophagy induction as a promising strategy for the treatment of these conditions.

Keywords: autophagy; neurodegenerative disease; protein aggregates.

Publication types

  • Review

MeSH terms

  • Amyloid beta-Peptides / metabolism*
  • Animals
  • Autophagosomes / enzymology
  • Autophagosomes / genetics
  • Autophagosomes / metabolism*
  • Autophagy / drug effects
  • Autophagy / genetics*
  • Humans
  • Lysosomes / drug effects
  • Lysosomes / metabolism
  • Neurodegenerative Diseases / drug therapy
  • Neurodegenerative Diseases / genetics
  • Neurodegenerative Diseases / metabolism*
  • Neurodegenerative Diseases / physiopathology
  • Neurons / metabolism*
  • Neurons / pathology
  • TOR Serine-Threonine Kinases / genetics
  • TOR Serine-Threonine Kinases / metabolism*
  • alpha-Synuclein / metabolism*

Substances

  • Amyloid beta-Peptides
  • alpha-Synuclein
  • TOR Serine-Threonine Kinases